Sofa Beds: Convenience Without Compromise

Posted on by

LONDON, October 16, 2012 /PRNewswire/ --

Sofas beds are the most efficient way to maximise your living space while still having room for guests to sleep comfortably. There is no longer any need to compromise on style when selecting the convenience of a sofa bed. Modern ranges offer the design of a great sofa, and hide a bed mechanism inside until it's needed.

Winter is traditionally the time when guests need to stay over. Over-indulgence during the Christmas period, dangerous winter driving conditions and long, dark nights mean that travelling home can be treacherous. Choosing a comfortable sofa bed can make all the difference, especially if your living space is tight.

With a huge range of stylish, attractive sofa beds, CSL have the space solution for you. Whether you want a soft, easy-care fabric sofa bed, an eye-catching corner group with sleeping space, or a classic leather sofa, CSL will have something for you.

Canny shoppers looking for the best deals will discover incredible discounts on their sofa beds at CSL and easy payment options to make coming to a decision easier. With a lifetime guarantee across the range and the option to return your sofa if you aren't completely happy - options that aren't offered by many other retailers.

If you're starting to think about how to accommodate guests in winter, you can see how your chosen sofa bed will look in your room by using CSL's In My Room iPhone app. Simply take a quick snap of your room, upload it to the app and place the sofa in the image. If it looks right, the sofa could be with you within 72 hours.

A good sofa bed is a great investment and guarantees happy guests who can get a good night's sleep with minimum inconvenience all-round. With CSL's stylish range you can find a sofa bed to enhance your living space, impress visitors and still offer convenient functionality for overnight stays. All this comes with the peace of mind offered by a lifetime guarantee and simple finance arrangements so you can relax in real style and comfort knowing that you made the right choice.

For more information on the full range of sofas on offer please visit http://www.csl-sofas.co.uk/ or walk into one of our sofa stores:

Blackpool Sofa Centre Oxford Square Blackpool Lancashire FY4 4DP Sophie Spencer Sophie.Spencer@csl-furniture.co.uk +44(0)1942-296472

Read more:

Sofa Beds: Convenience Without Compromise

Mind Movies Releases an Enhanced Version of Its Popular Law of Attraction Video Vision Board Creation Tool Endorsed by …

Posted on by

Mind Movies, the San Diego-Based Personal Development Company, Announced This Week the Release of a Faster, More Robust Version of Its Highly Popular Law of Attraction Video Vision Board Creation Tool, Mind Movies. Over 1 Million People Worldwide Have Received Access to Mind Movies, With Thousands More Coming On Each Week.

San Diego, CA (PRWEB) October 16, 2012

This faster, more feature-rich version is the third version of the companys popular Mind Movies video vision board creation tool, first released in 2010.

Mind Movies 3.0 is an easy drag-and-drop video vision board creation tool that anyone can use to create their own dynamic, moving video vision board in as little as 10 minutes.

Customers can easily upload their own inspiring images, uplifting music and positive present-tense affirmations or choose the ones in the tools built-in library. Customers can then watch their completed Mind Movie on their computer or laptop, or download it to their iPhone or mobile device to take it with them wherever they go and watch it whenever they like.

Mind Movies 3.0 was developed to support customers in realizing their dreams based on the principles of the Law of Attraction, a Universal law made popular by the best-selling book and hit film, The Secret, which states that like energy attracts like energy.

After they create their own personalized Mind Movie, we recommend that our customers watch their video vision board for three minutes every morning and three minutes every evening, said Ledwell. This helps them to visualize their goals on a regular basis and to attract to them the people, resources and opportunities they need to achieve their goals.

The Mind Movies video vision board creation tool has been endorsed by many of the stars of the film The Secret, including Bob Proctor, Bob Doyle and Joe Vitale.

Most of us live a reactionary life where we are bombarded by the negative images from mainstream media news. This product allows you to choose what you want to absorb and to reprogram your mind in a positive way," said Vitale. When you combine music, imagery and affirmations that you choose, the result is incredible.

Over 1 million people worldwide have already received Ledwells free pre-made Mind Movies in the areas of health, relationships, money and friends and family.

Read the original post:

Mind Movies Releases an Enhanced Version of Its Popular Law of Attraction Video Vision Board Creation Tool Endorsed by ...

Institute of Medicine Elects Lynda Chin to Membership

Posted on by

Select honor recognizes leaders in fields of medicine and health for professional achievements and commitment to service

Newswise HOUSTON - Lynda Chin, M.D., professor and chair of Genomic Medicine and scientific director of the Institute for Applied Cancer Science at The University of Texas MD Anderson Cancer Center, has been elected to the Institute of Medicine (IOM) of the National Academies.

Membership recognizes physicians and scientists who have made major contributions to the advancement of the medical sciences, health care and public health. Fewer than 70 new members and 10 foreign associates are elected each year.

"I'm honored to be selected as an IOM member by such a prestigious scientific group of colleagues." Chin said. "I'm fortunate to be part of the genomic revolution that contributes to making personalized medicine a reality. I thank the talented trainees and researchers in my lab, and my many collaborators, for their creative thinking, persistence and hard work."

Current IOM members elect new members annually from candidates nominated for their professional achievements, expertise to contribute to IOM research and commitment to service. Election is considered one of the highest honors in the fields of medicine and health. Currently there are approximately 1,700 IOM members representing the health care professions, as well as the natural, social and behavioral sciences.

Chin is a leader in translational genomic medicine, serving on multiple high-profile scientific committees and often publishing her work in top-tier journals. Chin employs an integrated genomic, genetic and biological program framework to identify novel cancer genes and translate these discoveries into productive drug discovery efforts. Her research focuses on the genesis, progression and maintenance of cancer, specifically glioblastoma and melanoma. She has made high-impact scientific discoveries in multiple fields that span transcription, telomere biology, mouse models of human cancer, oncogenomics and personalized cancer medicine.

The goal of Dr. Chin's research program is to translate basic science discoveries into validated therapeutic targets and biomarkers as well as innovative combination strategies. Chin also serves in a leadership role for The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium. For the TCGA, she is both the principal investigator of a Genome Data Analysis Center working to develop novel tools to manage, integrate and process the wealth of the data that TCGA generates, as well as the co-PI of a Genome Characterization Center. She also leads both the GBM and melanoma analysis working groups in TCGA.

Established in 1970 by the National Academy of Sciences, the IOM is recognized as a national resource for independent, scientifically informed analysis and recommendations on health and health care. IOM members volunteer their time to serve as experts on rigorous research studies to answer questions of national importance posed by political decision makers, such as Congress, as well as the public.

Chin joins a select group of colleagues at MD Anderson who are also IOM members: Ellen Gritz, Ph.D., chair of Behavioral Science (2007), Ronald DePinho, M.D., president (2004) and John Mendelsohn, M.D. professor in the Department of Experimental Therapeutics and co-director of MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (1997).

About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. For eight of the past 10 years, including 2011, MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.

Read more from the original source:

Institute of Medicine Elects Lynda Chin to Membership

Institute of Medicine Elects Four New Members from Penn Medicine

Posted on by

PHILADELPHIA Four professors from the Perelman School of Medicine have been elected members of the Institute of Medicine (IOM), one of the nation's highest honors in biomedicine, with a total of six representing four schools at the University of Pennsylvania.

The new members bring Penn Medicines total to 61. The newly elected members raise IOM's total active membership to 1,732 and the number of foreign associates to 112. With an additional 84 members holding emeritus status, IOM's total membership is 1,928.

Established in 1970 by the National Academy of Sciences, IOM has become recognized as a national resource for independent, scientifically informed analysis and recommendations on health issues. With their election, members make a commitment to volunteer their service on IOM committees, boards, and other activities.

The new Penn IOM members:

Gustavo D. Aguirre, V.M.D., Ph.D., is a professor of Medical Genetics and Ophthalmology, School of Veterinary Medicine. He has led efforts to develop gene therapy to treat various forms of blindness. Modeling the visual disorders in dogs, he and colleagues have cured retinal degeneration in the animalsbreakthroughs that have laid the groundwork for human clinical trials. Aguirre earned his undergraduate, veterinary and doctoral degrees from Penn. He is the recipient of numerous honors and awards for his work, including an honorary Doctor of Philosophy degree from the University of Gteborg, Sweden; the WSAVA/Waltham International Award for Scientific Achievement; the Foundation Fighting Blindness Trustee Award and Scientist of the Year Award; the O.N.C.E. International Prize for R&D in Biomedicine and New Technologies for the Blind; and the Paul Kayser International Award in Retina Research. He was recently elected a Fellow of the Association for Research in Vision and Ophthalmology.

Shelley L. Berger, Ph.D., is a Penn Integrates Knowledge Professor and Daniel S. Och University Professor, in the Department of Cell and Developmental Biology and Department of Genetics, Perelman School of Medicine, and in the Department of Biology, School of Arts and Sciences. She also serves as Director of the Epigenetics Program at the Perelman School. Berger earned her B.S. and Ph.D. degrees from the University of Michigan; was a post-doctoral fellow at Massachusetts Institute of Technology; and was previously Hilary Koprowski Endowed Professor at Wistar Institute. Her work advanced understanding of eukaryotic gene regulation by helping to unify the fields of transcription and chromatin regulation. The major focus of her research is to define the mechanisms by which epigenetic modifications affect chromatin structure (the combination of DNA and proteins found in chromosomes) and gene expression in normal and diseased states, in particular, during chromatin remodeling in spermatogenesis, senescence and aging, and underlying organismal-level behavior. Her work has also elucidated modifications of the tumor suppressor p53 and whether its alterations are central to oncogenesis. Berger has organized numerous international meetings on chromatin; has served as Senior Editor of the journal Molecular and Cellular Biology; and participates on advisory committees for several research institutions and chromatin-focused pharmaceutical and biotechnology companies. She has served on international committees to establish nomenclature for histone-modifying enzymes, and to create the NIH-sponsored Human Epigenome Project. She is also lead investigator on an NIH research award on Epigenetics and Aging and a recipient of the Ellison Foundation Senior Scholar Award in Aging.

Nancy M. Bonini, Ph.D., is the Florence R.C. Murray Professor of Biology in the Department of Biology, School of Arts and Sciences, and is an Investigator of the Howard Hughes Medical Institute. Her research uses the fruit fly Drosophila melanogaster to gain insight into neurodegenerative diseases, including Alzheimers, Parkinsons, Huntingtons, and amyotrophic lateral sclerosis. By recreating features of these diseases in flies, her team has helped identify disease mechanisms and potential targets for ameliorating some of the damage they cause. Bonini received her Ph.D. in Neuroscience from the University of Wisconsin-Madison. She has earned multiple awards from the Huntingtons Disease Society of America and the Hereditary Disease Foundation, and in 2009 received an NIH EUREKA award for highly innovative research. Bonini is a Fellow of the American Association for the Advancement of Science and was recently elected a member of the National Academy of Sciences.

Carl H. June, M.D., is the Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, and the Program Director of Translational Research, Abramson Family Cancer Research Institute. His laboratory studies various mechanisms of lymphocyte activation relating to immune tolerance and adoptive immunotherapy. In 2011, his research team published findings detailing a new therapy in which patients with refractory and relapsed chronic lymphocytic leukemia were treated with genetically engineered versions of their own T cells. The treatment has now also been used with promising results to treat children with refractory acute leukemia. June is a graduate of the U.S. Naval Academy and Baylor College of Medicine. He had graduate training in immunology and malaria at the World Health Organization, Geneva, Switzerland, and post-doctoral training in transplantation biology at the Fred Hutchinson Cancer Research Center. June has received numerous awards and grants for his innovative work, including a Bristol-Myers Squibb Company Freedom to Discover Research Grant; the William B. Coley Award from the Cancer Research Institute; the Ernest Beutler Prize from the American Society of Hematology; and The Joan Miller and Linda Bernstein Gene Therapy Ovarian Cancer Award from the Alliance for Cancer Gene Therapy.

Mitchell D. Schnall, M.D., Ph.D., is the Eugene P. Pendergrass Professor of Radiology, and the Chair of the Radiology Department, Perelman School of Medicine. He received his undergraduate degree, medical degree, and Ph.D. from Penn. Schnall is an international leader in translational biomedical imaging research. His work has led to fundamental changes in the imaging approaches to breast and prostate cancer. In addition, he has had a significant influence on emerging technologies, such as optical imaging.Schnall has played a critical role in efforts to organize cancer clinical and translational imaging research in the U.S. and has been the principal investigator of numerous team-science initiatives.He served as Deputy Chair of the American College of Radiology Imaging Network (ACRIN) from 1999-2007, and in 2008 became ACRIN Chair.Under his leadership, ACRIN completed the landmark National Lung Cancer Screening trial that demonstrated the ability of low-dose CT lung cancer screening to reduce lung cancer mortality by 20% in high risk patients.Schnall was one of the architects of the merger of the Eastern Cooperative Oncology Group (ECOG) and ACRIN to form the new ECOG-ACRIN Cancer Research Group, which he now co-chairs. He is also a member of the American Society for Clinical Investigation and the Association of American Physicians.

Kevin G.M. Volpp, M.D., Ph.D., is the founding Director of the Center for Health Incentives and Behavioral Economics at the Leonard Davis Institute; Co-Director of the Penn Medicine Center for Innovation, and a Professor of Medicine at the Perelman School of Medicine and Health Care Management at the Wharton School. He is also the Director of the NIH-funded Penn CMU Roybal P30 Center in Behavioral Economics and Health, one of two such NIH- funded centers in the U.S. Volpps research on the impact of financial and organizational incentives on health behavior and health outcomes has been recognized by numerous awards including the Presidential Early Career Award for Scientists and Engineers; the Alice S. Hersh New Investigator Award from AcademyHealth; Time Magazines 2009 A-Z Advances in Health list for work on Incentives letter I; the British Medical Journal Group Award for translating Research into Practice, and the outstanding paper of the year from the Society of General Internal Medicine. He is a member of the editorial board of the Annals of Internal Medicine. He did his medical training at Penn and Brigham and Womens hospital, has a Ph.D. in Applied Economics and Managerial Science from the Wharton School, and is a staff physician at the Philadelphia Veterans Affairs Medical Center.

More:

Institute of Medicine Elects Four New Members from Penn Medicine

Personalized genomic medicine: How much can it really empower patients?

Posted on by

ScienceDaily (Oct. 15, 2012) Personalized genomic medicine is hailed as a revolution that will empower patients to take control of their own health care, but it could end up taking control away from patients and limiting their treatment choices, concludes an article in the Hastings Center Report. A commentary responding to the article, by the editorial director of Health and Family at Consumer Reports, also appears in the journal.

Genomic science provides two categories of data, the authors write: pharmacogenomic information and genomic susceptibility information. Pharmacogenomic information forecasts how an individual might respond to a particular therapy. Genomic susceptibility testing predicts a patient's chances of warding off or succumbing to an environmental threat or disease.

Genomic medicine's stakeholders -- including direct-to-consumer genetic testing companies, private research centers, and the National Institutes of Health -- are deeply invested in promoting how this information will benefit patients. The authors call this "empowerment rhetoric." And yet the added knowledge that comes from both pharmacogenomic information and genomic susceptibility information could have a negative impact on how much power a patient really has.

The results gleaned from pharmacogenomic information could pressure patients to comply with physicians' recommendations, the authors suggest, because molecular profiling would allow doctors to give orders with more authority. "In fact, because genomic medicine generates more risk information and makes that information the key lens for approaching health and disease, patients may actually find that they have less ability to influence health care decisions and treatments," the authors state.

The virtues of genomic susceptibility information could also go awry. First, because disease prevention relies heavily on lifestyle changes, responsibility is shifted from doctor to patient. Patients who don't make the "right" choices could be deemed irresponsible, the article says. Second, genomic information can for the time being only reveal the health risks of groups of people. Rather than provide individualized assessments, it classifies people into "genetic superfamilies." The authors argue that "population classification schemes based on racial and ethnic categories can be actively disempowering for individuals, by encouraging potentially prejudicial associations between their group affiliations and health care risks."

Patient empowerment is marketed as a paradigm shift because it puts medical data in the hands of the consumer, not just the doctor. But the authors conclude that the focus on empowerment could clash with the reality of what patients are willing or able to do with the information they receive. "The idea of patient empowerment may run up against not only the limits of patients' control over their health, but also the limits of patient control over health care systems," the article says.

The authors are Eric T. Juengst, director of the Center for Bioethics and professor in the Departments of Social Medicine and Genetics at the University of North Carolina, Chapel Hill; Michael A. Flatt, a doctoral candidate in sociology at Case Western Reserve University; and Richard A. Settersten, Jr., professor of social and behavioral health sciences and endowed director of the Hallie E. Ford Center for Healthy Children and Families in the College of Public Health and Human Sciences at Oregon State University.

In a commentary on the article, Ronni Sandroff, editorial director of Health and Family at Consumer Reports, acknowledges that pharmacogenomics could take control away from a patient if a health insurance company opted not to cover a medicine that was shown to work infrequently in people with a particular genetic makeup. But even an increase in patient empowerment can have downsides if it shifts the responsibility for health care to patients and stigmatizes people who do not, or cannot, make the "right" health choices. Sandroff notes that the greatest challenge in preventive medicine is getting people to eat less, exercise more, and reduce stress. Whether or not genetic susceptibility information will actually empower patients by propelling them toward healthier lifestyles is unknown. "This is a question that needs more serious study," she writes.

Still, Sandroff says that consumer participation in genetic health research -- "a new and growing factor" -- could help advance scientific knowledge. "That makes it something that professionals should be wondering how to enhance and encourage, rather than fear," she writes.

Share this story on Facebook, Twitter, and Google:

The rest is here:

Personalized genomic medicine: How much can it really empower patients?

RMANJ To Present 24 Abstracts At The American Society for Reproductive Medicine Annual Meeting

Posted on by

BASKING RIDGE, N.J., Oct. 16, 2012 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) will be presenting 24 abstracts at the upcoming American Society for Reproductive Medicine Annual Meeting to be held October 20-24, 2012, in San Diego, California.

(Logo: http://photos.prnewswire.com/prnh/20120402/NY80340LOGO )

"We are very proud of the outstanding research conducted by the team at RMANJ. This year, our research covers important topics in reproductive medicine ranging from the continued validation of genetic screening to the reality of single embryo transfer in IVF," said Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., founding partner of RMANJ. "We are particularly excited to present the findings from our BEST Trial, the first well-controlled clinical trial comparing IVF pregnancy rates in a group of women receiving a single embryo transfer with comprehensive chromosome screening compared to a group receiving traditional morphology-based double embryo transfer. These findings are poised to fundamentally change the way IVF is practiced."

2012 ASRM ABSTRACT LIST

Monday, October 22, 2012

Morphology plus ploidy: a prospective study comparing traditional morphology-based selection for single embryo transfer (SET) with comprehensive chromosome screening (CCS) results (O-57)Eric FormanOral Monday 5:15-5:30 p.m. Outcome Predictors-Lab: ART

Comparison of clinical outcomes between genetically similar groups of in vitro fertilization patients (O-83)Shefali ShastriOral Monday 5:45-6:00 p.m. Reproductive Endocrinology: Research

Tuesday, October 23, 2012

Blastocyst euploid selective transfer (BEST): an RCT of comprehensive chromosome screening-single embryo transfer (CCS-SET) vs. double embryo transfer (DET) equivalent pregnancy rates, eliminates twins (O-161)Eric FormanOral Tuesday 4:15-4:30 p.m. Outcome Predictors-Clinical: ART

Trophectoderm is predictive of the inner cell mass and newborn mitochondrial DNA mutation load (O-194)Nathan TreffOral Tuesday 4:30-4:45 p.m. Reproductive Biology: Human Studies

Here is the original post:

RMANJ To Present 24 Abstracts At The American Society for Reproductive Medicine Annual Meeting

Infor Healthcare Applications to Unify Financials at the Institute for Transfusion Medicine

Posted on by

NEW YORK, NY--(Marketwire - Oct 16, 2012) - Infor, a leading provider of business application software serving more than 70,000 customers, today announced the Institute for Transfusion Medicine (ITxM), one of the nation's foremost providers of transfusion medicine and related services, has upgraded to the latest version of Infor Healthcare Revenue Management to integrate its outpatient records and core receivalbes systems into a single, unified solution.With the functionality to manage both client and patient billing, the application will help reduce manual entry requirements and automate billing to help the company completefinancial processes more efficiently.In addition, the upgrade will allow ITxM to benefit from the latest platform enhancements and facilitate enriched system support.

News Points

ITxM Quote "Prior to our Infor upgrade it was difficult to track and process payments because users had to access separate systems to obtain the necessary data," said Keir Josephson, director, IT Strategy & Delivery, ITxM. "Now our entire outpatient records system is integrated with our core receivable system, enabling us to manage our billing processes, whether patient or client, within a single, unified solution."

Infor Quote "Whether it be a multi-site hospital, reference laboratory or healthcare specialty provider, managing billing and revenue cycles is essential to financial performance," said Kevin Curry, senior vice president and general manager for Healthcare, Infor. "Infor Healthcare solutions have the flexibility to handle transactions from a variety of business models with the functionality to support all processes within one solution, helping healthcare organizations to proactively manage the revenue cycle for maximum efficiency and profitability."

Additional Resources Note: registration may be required to access online content

About ITxM The Institute for Transfusion Medicine(SM) (ITxM(SM)) is one of the nation's foremost organizations specializing in transfusion medicine and related services. Headquartered in Pittsburgh with offices in Chicagoland, ITxM provides patients and medical facilities with comprehensive transfusion support, including medical staff consultation and treatment plans, along with testing and delivery of blood products. ITxM business units work together to develop, deliver and influence the highest quality patient care in transfusion medicine and related services. For more information, visit http://www.itxm.org.

About Infor Infor is the world's third-largest supplier of enterprise applications and services, helping more than 70,000 large and mid-size companies improve operations and drive growth across numerous industry sectors.To learn more about Infor, please visit http://www.infor.com.

Read the rest here:

Infor Healthcare Applications to Unify Financials at the Institute for Transfusion Medicine

Sensors for Medicine and Science Changes Company Name to Senseonics

Posted on by

GERMANTOWN, MD--(Marketwire - Oct 16, 2012) - Sensors for Medicine and Science, Inc., a privately held medical device company focused on the development and commercialization of the first fully implantable, long-term continuous glucose monitoring (CGM) system, today announced its new company name, Senseonics.

"The new Senseonics name really captures the essence of what we're about and what makes us unique," said Tim Goodnow, PhD., President and Chief Executive Officer."The name combines sense (to detect), eon (long time) and -ics (suffix to denote body of knowledge) to signal our unequivocal focus on continuous glucose sensors designed for accurate, long-term wear by people with diabetes.Our first generation sensor, currently in clinical studies, is targeted to last for up to six months of continuous wear."

Along with its new name, the company also announced it has submitted its pivotal clinical study protocol to the Medicines and Healthcare products Regulatory Agency (MHRA) of the U.K. and the Federal Institute for Drugs and Medical Devices (Bundesinstitut fr Arzneimittel und Medizinprodukte, BfArM) in Germany.

The pivotal study is titled PRECISE (Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor), and its objective is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring system over 180 days.

The PRECISE study requires clinical participants with diabetes to use the glucose sensor in the arm and to wear the external receiver to obtain continuous glucose readings during the 180-day study duration. The study will also evaluate safety of the Senseonics CGM system usage during in-clinic and home wear.

"All the study investigators are very much looking forward to proceeding with this first large study of a long-term implantable glucose sensor," said primary investigator Dr. Roman Hovorka, University of Cambridge, UK."This has the potential to be an important technology to help our patients better manage their diabetes."

The PRECISE study will be conducted in three clinical sites in Germany and two in the U.K.Enrollment in the trial will include up to 50 subjects with diabetes. The trial builds upon previous clinical experience which demonstrated high accuracy performance for the first time for an implanted biosensor.

"The filing of the PRECISE pivotal study application represents an important milestone in the development of our glucose sensing system, and the study will allow us to gather clinical data for European regulatory approval," said Goodnow.A successful execution of the PRECISE study is expected to support an application for a CE mark in Europe.

About Senseonics Senseonics, Incorporated (formerly Sensors for Medicine and Science, Inc.) is developing the first fully implantable continuous glucose sensor designed for highly accurate, long-term sensor wear. The Senseonics Continuous Glucose Monitoring System includes a miniaturized sensor and receiver. Based on proprietary breakthrough fluorescence sensing technology, the sensor is inserted into the subcutaneous space under the skin and wirelessly transmits glucose levels to an external receiver.After insertion, the sensor functions noninvasively, automatically, and continuously. The system is intended to enable people with diabetes to confidently live their lives with ease.For more information on Senseonics, please visit http://www.senseonics.com.

About Diabetes Diabetes affects nearly 26 million people in the U.S. and an estimated 350 million worldwide. Monitoring of glucose levels is essential to managing the disease and avoiding its debilitating complications.Continuous glucose monitoring has the potential to further help diabetes patients examine how their glucose level reacts to insulin, exercise, food, and other factors. Studies have shown that CGM is effective at improving glucose control while minimizing severe hypoglycemia.Accurate continuous glucose monitors are also a key component of the promising artificial pancreas ongoing studies that could potentially offer additional freedom in the management of diabetes.

See the original post here:

Sensors for Medicine and Science Changes Company Name to Senseonics

Fake med student forged ID, university says

Posted on by

The University of Auckland's medical school says it is "reasonably sure" a fake medical student did not deal with hospital patients.

An investigation has been launched by the university to figure out how a student managed to pose as a medical student for two years.

The dean of the Medical and Health Sciences Faculty, John Fraser, said it was unclear whether the student got through the doors of Auckland Hospital.

"We understand that he assigned himself to a group, but whether he actually was there, on site, and engaged with the patients, we are reasonably sure that didn't occur," Professor Fraser told TVNZ.

The man also forged a student identification badge, which he was seen wearing.

The man, yet to be named, had even fooled his family into thinking he was training legitimately to be a doctor.

Starting out as a health science student and failing to get into medical school, he took part in second and third year medical studies and was involved in human cadaver dissection.

Prof Fraser said the man deceived everyone in the class and his fellow, legitimate, students were feeling betrayed and angry.

"We had a formal meeting with students yesterday, their reaction was not surprisingly hurt and upset and there was some degree of anger.

The university's medical programme head Warwick Bagg said the bogus student would be referred to the appropriate health services to help him.

Original post:

Fake med student forged ID, university says

Fake med student forged ID – university

Posted on by

The University of Auckland's medical school says it is "reasonably sure" a fake medical student did not deal with hospital patients.

An investigation has been launched by the university to figure out how a student managed to pose as a medical student for two years.

The dean of the Medical and Health Sciences Faculty, John Fraser, said it was unclear whether the student got through the doors of Auckland Hospital.

"We understand that he assigned himself to a group, but whether he actually was there, on site, and engaged with the patients, we are reasonably sure that didn't occur," Professor Fraser told TVNZ.

The man also forged a student identification badge, which he was seen wearing.

The man, yet to be named, had even fooled his family into thinking he was training legitimately to be a doctor.

Starting out as a health science student and failing to get into medical school, he took part in second and third year medical studies and was involved in human cadaver dissection.

Prof Fraser said the man deceived everyone in the class and his fellow, legitimate, students were feeling betrayed and angry.

"We had a formal meeting with students yesterday, their reaction was not surprisingly hurt and upset and there was some degree of anger.

The university's medical programme head Warwick Bagg said the bogus student would be referred to the appropriate health services to help him.

Visit link:

Fake med student forged ID - university

Cedar City pushing to establish osteopathic medical school

Posted on by

The Cedar City Office of Economic Development wants to establish a school of osteopathic medicine in that community.

It says it is beginning the groundwork to open the school in what it describes as a joint effort of community leaders, business leaders, educators, health professionals and interested residents and students.

The economic development office says it is consulting with Colorado-based Rocky Vista Universitys College of Osteopathic Medicine to help it establish a school. Rocky Vistas first class of physicians graduated in May 2012.

In the United States, there are two types of licensed physicians that practice medicine. Most physicians hold the M.D. or Doctor of Medicine degree. Osteopathic physicians hold the D.O. or Doctor of Osteopathic Medicine degree. The medical training for an M.D. and D.O. is virtually indistinguishable. D.O. physicians are licensed to practice medicine in all 50 states, with a large percentage going into primary care.

Copyright 2012 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Continued here:

Cedar City pushing to establish osteopathic medical school

UMass Medical School Building Earns LEED Silver

Posted on by

Tuesday, October 16, 2012, 10:49am

The Ambulatory Care Center (ACC) at the University of Massachusetts Medical School's Worcester campus has earned LEED Silver certification from the U.S. Green Building Council, the first building in the school's history to achieve such status.

The ACC opened in June 2010, and after a detailed review of the building's design, construction and operational data, the Green Building Certification Institute verified the LEED Silver certification on Sept. 20. Built by the Medical School in collaboration with its clinical partner the UMass Memorial Medical Center, the 253,000-square-foot ACC is home to a mix of patient-care, clinical research and educational activities.

"We are pleased to have earned this important certification for the new building," said Terence R. Flotte, MD, the Celia and Isaac Haidak Professor in Medicine, executive deputy chancellor, provost, dean of the School of Medicine and professor of pediatrics and microbiology & physiological systems at UMass Medical School. "It is only fitting that facilities like the Ambulatory Care Center, that are designed to improve human health are respectful of the health of our environment."

LEED stands for "Leadership in Energy and Environmental Design" and is a third-party certification system created by the USGBC for "green building" construction and renovation projects. It's regarded as the premier certification program for sustainable construction in the country.

To meet the high standards required for LEED Silver certification, numerous sustainable features were integrated into the ACC. For example, the building's design and orientation helps prevent solar heat gain, thereby lowering the need for mechanical cooling. The building has a white roof to diminish the "heat island effect" and reflect rather than absorb heat; a tight exterior building envelope with tinted, reflective, and insulated glass; and an east-west building orientation to minimize the number of south-facing windows.

Water use in the ACC is approximately 30-percent less than a conventional building because of automatic low-flow/low-flush plumbing fixtures. Electricity consumption is reduced by sophisticated controls for heating, cooling and lighting. A special "commissioning agent" was brought in to oversee the design and installation of the mechanical, electrical and plumbing systems to insure they were the most efficient possible given the use of the building, and are functioning as expected.

Payette of Boston was the architect for the ACC; Consigli Construction of Milford was the construction manager and general contractor.

See the original post here:

UMass Medical School Building Earns LEED Silver

Trespass notice issued to fake medical student

Posted on by

By Tom McRae

The University of Auckland medical school still can't rule out a man posing as a student didn't have direct contact with patients.

An investigation is underway and the man has been issued with a trespass notice after he went to great lengths to pose as a medical student for two years.

Watched closely by security, students today filed into their 8am lecture. Many are shocked at the deception by someone they thought was a fellow student.

[Theyre] not surprisingly very upset and hurt, and [there is] some degree of anger, says Medical and Health Sciences dean Professor John Fraser.

The imposter studied biomedical science in 2010 but failed to get into medical school. So for two years he faked it, continuing to attend classes.

He doesn't give a good explanation, says head of the universitys medical programme Dr Warwick Bagg. What we need to understand with this individual is he's in great distress. His family is in great distress and we're quite concerned for his wellbeing.

The man took part in dissecting dead bodies, and as a third-year student he was eligible to attend hospital site visits and interact with patients one-on-one.

Our investigations to date show that he has not had interaction with patients on the wards, says Dr Bagg.

But a student who wanted to remain anonymous says he did have access to confidential patient information while at the hospital. The class is also concerned he was able to carry out medical procedures on other students.

Read the original here:

Trespass notice issued to fake medical student

Fake student prompts medical school review

Posted on by

Auckland University's medical school is carefully reviewing its practices after a man pretended to be a medical student for two years.

The student failed to gain entry into the medical school in 2010 but has since attended classes and taken part in a number of school activities, including the study of human cadavers.

He was detected when a group assignment with his name on it was submitted which didn't match any name on the class list.

Professor John Fraser says the school has no evidence the students interacted with any patients, but they were still concerned he was able to pretend he was a student for two years.

"Obviously there are areas, particularly in the medical programme, where we do need to tighten up our procedures on entry and access," he told a media conference.

"This student went to some considerable length to hide the fact that he wasn't eligible, and although we are very, very concerned that he was able to get away with that, I would like to tell the public that our university operates on the highest possible standards."

Associate Professor Warwick Begg said the school's hospital partners had all been in touch trying to see if the fake student had any contact with patients.

"As far as we know we have not been able to find any evidence to date that he did interact with a patient."

Prof Fraser said the fake student's family weren't aware of his scam.

He said the fake student was in some distress, and they were concerned for his wellbeing.

Read the original:

Fake student prompts medical school review

Liberty man charged with burglarizing village apartment

Posted on by

Published: 8:57 AM - 10/16/12 Last updated: 8:59 AM - 10/16/12

LIBERTY- Authorities made a quick arrest after a reported burglary of an apartment on South Main Street in the village

Russell Jackson, 26, of Liberty, was charged on Thursday with felony burglary and misdemeanor petty larceny after police say Liberty officers and a state police K-9 unit found him with the stolen items within an hour of getting a description of the suspect.

He was arraigned and taken to the Sullivan County Jail on $25,000 bail.

Victor Whitman

Read more:

Liberty man charged with burglarizing village apartment

Liberty Global’s UPC Deploys Jungo Panorama to Enable Remote Management of Horizon Platform

Posted on by

AMSTERDAM--(BUSINESS WIRE)--

BBWF, 16-18 October 2012 Jungo, now part of Cisco, a leading provider of gateway and remote management solutions for home broadband service offerings, today announced that its Panorama remote management system has been successfully deployed by UPC in the Netherlands, a subsidiary of Liberty Global, the leading international cable operator, with the launch of the Horizon platform.

Highlights:

Supporting quotes:

Gerrit Goedkoop, Vice President Customer Care, Liberty Global

Jungos Panorama has shown to be a fantastic addition to the Horizon platform, enabling us to effectively manage the Horizon Gateway. He continued Panorama enables our customer support teams to identify real-life user issues in real time, and with the simplicity and effectiveness of the user interface resolve their issues in a faster and more effective way.

Eran Rom, Chief Executive Officer, Jungo, now part of Cisco

Panorama is a unique solution designed to manage the entire digital home. Liberty Global is a strategic partner for us and its selection of Jungo demonstrates that we are able to scale our solution to offer a whole home management to any operator, regardless of size or market.

About Jungo

Jungo, now part of Cisco, is a leading provider of software products and solutions that power residential broadband service offerings and connectivity solutions. Our residential broadband products enable 40 million of the worlds residential gateways. Our connected home, application framework and remote management solutions let service providers easily launch value-added broadband services and manage and monitor their delivery. Jungo's unique home broadband offerings enable service providers to accelerate the introduction of a variety of innovative, revenue generating digital home services, while enhancing their competitive edge and reducing operational costs.

Excerpt from:

Liberty Global’s UPC Deploys Jungo Panorama to Enable Remote Management of Horizon Platform

Liberty Media Corporation Announces Third Quarter Earnings Release and Conference Call

Posted on by

ENGLEWOOD, Colo.--(BUSINESS WIRE)--

Liberty Media Corporation (Nasdaq: LMCA, LMCB) will release its third quarter earnings on Tuesday, November 6th, at 11:45 a.m. (ET). Greg Maffei, Liberty Medias President and CEO, will host the call. During the call, Mr. Maffeiwill discuss the company's financial performance.

Please call Premiere Conferencing at (888) 602-6363 or (719) 325-2475 at least 10 minutes prior to the call. Callers will need to be on a touch-tone telephone to ask questions. The conference administrator will provide instructions on how to use the polling feature.

Replays of the conference call can be accessed through 1:45 p.m. (ET) on November 13th, by dialing (888) 203-1112 or (719) 457-0820 plus the passcode 5834108#.

In addition, the third quarter earnings conference call will be broadcast live via the Internet. All interested participants should visit the Liberty Media Corporation website at http://www.libertymedia.com/events to register for the webcast. Links to the press release and replays of the call will also be available on the Liberty Media website. The conference call and related materials will be archived on the website for one year.

About Liberty Media Corporation

Liberty Media (Nasdaq: LMCA, LMCB) owns interests in a broad range of media, communications and entertainment businesses, including its subsidiaries Atlanta National League Baseball Club, Inc. and TruePosition, Inc., its interests in Starz, LLC, SiriusXM, Live Nation Entertainment and Barnes & Noble, and minority equity investments in Time Warner Inc. and Viacom.

Read this article:

Liberty Media Corporation Announces Third Quarter Earnings Release and Conference Call

Liberty Interactive Corporation Announces Third Quarter Earnings Release and Conference Call

Posted on by

ENGLEWOOD, Colo.--(BUSINESS WIRE)--

Liberty Interactive Corporation (Nasdaq: LINTA, LINTB, LVNTA, LVNTB) will release its third quarter earnings on Tuesday, November 6th at 11:00 a.m. (ET). Greg Maffei, Liberty Interactives President and CEO, will host the call. During the call, Mr. Maffeiwill discuss the company's financial performance.

Please call Premiere Conferencing at (888) 455-2265 or (719) 457-2703 at least 10 minutes prior to the call. Callers will need to be on a touch-tone telephone to ask questions. The conference administrator will provide instructions on how to use the polling feature.

Replays of the conference call can be accessed through 1:00 p.m. (ET) on November 13th, by dialing (888) 203-1112 or (719) 457-0820 plus the passcode 7834540#.

In addition, the third quarter earnings conference call will be broadcast live via the Internet. All interested participants should visit the Liberty Interactive Corporation website at http://www.libertyinteractive.com/events to register for the web cast. Links to the press release and replays of the call will also be available on the Liberty Interactive website. The conference call and related materials will be archived on the website for one year.

About Liberty Interactive Corporation

Liberty Interactive Corporation operates and owns interests in a broad range of digital commerce businesses. Those interests are currently attributed to two tracking stock groups: Liberty Interactive Group and Liberty Ventures Group. The Liberty Interactive Group (Nasdaq: LINTA, LINTB) is primarily focused on digital commerce and consists of Liberty Interactive Corporations subsidiaries Backcountry.com, Bodybuilding.com, Celebrate Interactive (including Evite and Liberty Advertising), CommerceHub, MotoSport, Provide Commerce, QVC, Right Start, and Liberty Interactive Corporations interests in HSN and Lockerz. The Liberty Ventures Group (Nasdaq: LVNTA, LVNTB) consists of Liberty Interactive Corporations non-consolidated assets, including interests in AOL, Expedia, Interval Leisure Group, Time Warner, Time Warner Cable, Tree.com (Lending Tree), TripAdvisor and various green energy investments.

See original here:

Liberty Interactive Corporation Announces Third Quarter Earnings Release and Conference Call

Liberty Silver Closes Acquisition of Hi Ho Property to Expand Trinity Land Package

Posted on by

TORONTO, ONTARIO--(Marketwire - Oct 16, 2012) - Liberty Silver Corp. (LSL.TO)(LBSV) ("Liberty Silver" or the "Company") is pleased to announce that it has completed its transaction with Primus Resources, L.C. and a second property owner (collectively, "Primus") to acquire approximately 100 acres located adjacent to the former Trinity Mine on the Company''s Trinity property in Nevada (the "Hi Ho Property"). The Hi Ho Property was the only acreage not controlled by Liberty Silver or its joint venture partner Renaissance Gold Inc. ("Renaissance") on the Trinity land package.

"We are extremely pleased to have completed the transaction with Primus and appreciate their continued confidence," stated Geoff Browne, Chairman and CEO of Liberty.

The Hi Ho Property completes the land package controlled by Liberty Silver and Renaissance. The joint venture comprises over 10,500 acres of contiguous land in a historic Nevada mining district, which includes the Trinity Mine and several other exploration targets. US Borax operated the Trinity Mine from 1988 to 1989, where it produced over 5 million ounces of silver. Operations at the mine were suspended when silver prices declined to less than $5/oz in the late 1980''s. Based upon the drilling results available to the Company from the US Borax drill programs on the Hi Ho Property, it is expected that the inclusion of the Hi Ho Property has the potential to substantially increase the estimated silver resource in the Trinity Mine pit area (please see the Company''s December 2011 NI 43 101 resource estimate).The Company is also currently evaluating the internal data in conjunction with its recent drilling and geophysical data to determine future drilling targets. The data will be used to update the Company''s current NI 43-101 report and will be utilized as part of the previously announced scoping study, which is being completed in connection with the Company''s proposal to put the Trinity Mine back into production.

Richard Bedell, President and CEO of Renaissance comments, "The addition of the Hi Ho Property completes the Trinity land package and significantly increases the size of the potential resource given its close proximity to the existing pit and the historic drilling and assay data that Liberty has analyzed. We are extremely pleased with the progress that Liberty has made on the exploration and development of Trinity. Their approach has been professional, and we are very comfortable with their entire team and the assessment of the property''s potential. Trinity is one of the marquee properties in our portfolio and we remain very confident in Liberty''s ability to advance the project.We are fully supportive of Liberty Silver''s management and its technical team."

In closing the Hi Ho Property transaction, Liberty Silver paid cash consideration of US$250,000 plus transaction expenses, issued 2,583,333 Liberty Silver common shares (the "Liberty Silver Shares") to Primus at a deemed value of US$1,860,000 (US$0.72 per share), and also granted Primus a 2% net smelter royalty on future production from the Hi Ho Property. In addition, pursuant to a registration rights agreement between Liberty Silver and Primus, Liberty Silver will pay Primus additional consideration as follows:

"We have closely monitored the progress that Liberty Silver has made since they began operations at Trinity last year," stated Jim Marin of Primus. "They have a strong on the ground team, excellent board and management, supported by first class engineering and permitting consultants. We are very excited to be part of the project and look forward to their future success."

"Liberty Silver is very pleased to have the vendors as significant shareholders and appreciate their recognition of the future potential of the combined properties," added Mr. Browne.

The total consideration for the acquisition of the Hi Ho Property is being applied to Liberty Silver''s expenditure commitment under its earn-in agreement with Renaissance, pursuant to the applicable area of interest provisions. With the addition of the Hi Ho Property payment, Liberty Silver has contributed in excess of 85% of its required US$5,000,000 expenditure commitment to earn a 70% interest in the Trinity project. Pursuant to the terms of its earn-in agreement with Renaissance, Liberty Silver has until March 29, 2016 to incur the balance of its expenditure commitment and, in addition, produce a bankable feasibility study the following year.

"We continue to achieve each milestone set forth by our team," concluded Mr. Browne. "This acquisition not only has the potential to increase our current resource and the potential economics to bring the Trinity Mine back into production, but also moves us very close to meeting our earn-in requirements. Although the past week has been challenging for the Company, the board and management of Liberty Silver remain fully committed to its future. Importantly and as previously stated, investors are reminded that they should only rely on official statements and releases issued by the Company for information regarding its activities."

About Liberty Silver Corp.

See the original post here:

Liberty Silver Closes Acquisition of Hi Ho Property to Expand Trinity Land Package